UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36616 LogicMark, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or o ...

Revenue Performance - For the three months ended March 31, 2025, the company generated revenue of $289,037, a decrease of approximately 9.3% compared to $318,643 for the same period in 2024[234]. - Revenue from the company's network marketing business decreased by $10,532 or approximately 28.4%, while revenue from complementary health therapies decreased by $29,318 or approximately 10.4%[234]. Cost and Profitability - Cost of revenue increased by $17,528 or approximately 15.2%, amounting to $132,751 for the three months ended March 31, 2025[236]. - Gross profit for the three months ended March 31, 2025 was $156,286, representing a gross margin of 54.1%, down from 63.8% in the same period of 2024[239]. - Selling expenses increased by $12,704 or approximately 25.2%, totaling $63,052 for the three months ended March 31, 2025[241]. - Net loss increased by $9,825, resulting in a net loss of $712,919 for the three months ended March 31, 2025, compared to a net loss of $703,094 for the same period in 2024[247]. Cash Flow and Working Capital - As of March 31, 2025, the company had working capital of $23,775,576, significantly up from $1,656,571 as of December 31, 2024[248]. - Net cash used in operating activities for the three months ended March 31, 2025 was $1,453,874, compared to $1,243,460 for the same period in 2024[249]. - Net cash used in investing activities for the three months ended March 31, 2025 was $23,000,649, primarily from advances for investment[252]. - Net cash provided by financing activities for the three months ended March 31, 2025 was $22,994,658, compared to a net cash used of $899 in the same period of 2024[255]. Asset Management - As of March 31, 2025, the allowance for credit loss was recognized at $41,360, an increase from $32,857 as of December 31, 2024, reflecting a growth of approximately 25.3%[264]. - The carrying amounts of operating right-of-use assets were $189,059 as of March 31, 2025, down from $224,595 as of December 31, 2024, indicating a decrease of about 15.8%[261]. - The Company recorded inventory write-offs of $6,777 for the three months ended March 31, 2025, compared to $0 for the same period in 2024[259]. - The Company has not recognized any impairment losses on operating right-of-use assets and property, plant, and equipment as of March 31, 2025[261]. Revenue Recognition and Accounting Policies - The Company’s revenue recognition follows the five-step model under ASC Topic 606, ensuring that revenue reflects the transfer of goods and services to customers[268]. - The Company’s sales of skin care, health, and wellness products are recognized when control is transferred to the customer, with a return period of 60 days[271]. - The Company evaluates the need for an allowance for credit loss based on ongoing credit evaluations and current economic conditions[291]. - The Company has not hedged exposures denominated in foreign currencies, limiting direct foreign exchange risk[290]. - The adoption of ASU 2023-07 regarding segment reporting is expected to have no material impact on the consolidated financial statements[280]. Equity and Financing - The Company issued Representative's Warrants to purchase up to 115,500 shares at $4.4 per share, effective from October 13, 2023[266].

Revenue and Financial Performance - The Company recognized leasing revenue of approximately $2,991,000 for the three-month period ended March 31, 2025, compared to $4,253,000 for the same period in 2024, with PBRT services contributing approximately $1,642,000 and $2,649,000, respectively [97]. - Direct patient services revenues for the three-month period ended March 31, 2025, were approximately $3,121,000, a significant increase from $963,000 in the same period of 2024 [100]. - Revenues increased by $896,000 to $6,112,000 for Q1 2025 compared to $5,216,000 for Q1 2024 [107]. - Revenues from the leasing segment decreased by $1,262,000 to $2,991,000 due to lower Gamma Knife volumes and the expiration of two customer contracts [107]. - Direct patient services revenue increased by $2,158,000 to $3,121,000, primarily driven by the RI Companies following the acquisition on May 7, 2024 [107]. - Radiation therapy revenues from the acquired facilities and the Puebla facility totaled $2,374,000 for Q1 2025, compared to $0 for Q1 2024 [108]. - Total costs of revenue increased by $2,097,000 to $5,170,000 for Q1 2025 compared to $3,073,000 for Q1 2024 [113]. - Net loss attributable to American Shared Hospital Services increased by $744,000 to a loss of $625,000, or $0.10 per diluted share for Q1 2025 [123]. Assets and Liabilities - As of March 31, 2025, accounts receivable balances under ASC 606 were $6,120,000, compared to $1,882,000 as of March 31, 2024 [100]. - Working capital decreased by $4,821,000 to $11,032,000 as of March 31, 2025, compared to $15,853,000 at December 31, 2024 [125]. - The Company had cash, cash equivalents, and restricted cash of $11,491,000 as of March 31, 2025, an increase of $216,000 from December 31, 2024 [124]. - Long-term debt was $18,372,000 as of March 31, 2025, compared to $18,462,000 at December 31, 2024 [129]. - As of March 31, 2025, the Company had long-term debt of $19,926,000 on its condensed consolidated balance sheets [136]. Debt and Financing - The DFC Loan has a first tranche outstanding amount of $1,642,000 with a fixed interest rate of 3.67% and a second tranche of $1,806,000 at 7.49% [131]. - Interest expense increased by $84,000 to $433,000 for Q1 2025 due to increased borrowings [119]. - The Company is in compliance with all covenants related to the DFC Loan as amended and waived as of March 31, 2025 [133]. - The Company received a waiver and amendment from DFC for certain covenants as of December 31, 2023, and through December 31, 2024 [132]. Commitments and Obligations - Total commitments for purchasing and installing three Leksell Gamma Knife Esprit Systems and two Linear Accelerator systems amounted to $9,618,000 as of March 31, 2025 [138]. - The Company has commitments for service and maintenance of its Gamma Knife, LINAC, and PBRT equipment totaling $12,252,000 as of March 31, 2025 [140]. - The Company has an obligation to maintain a minimum fixed charge coverage ratio of 1.25 and a maximum funded debt to EBITDA ratio of 3.0 to 1.0 under the Credit Agreement [130]. Operational Developments - The Company acquired 60% of the equity interests of the RI Companies on May 7, 2024, which operate three radiation therapy facilities in Rhode Island [90]. - The Company operates ten domestic Gamma Knife units and one PBRT system in the United States as of March 31, 2025 [96]. - The Company’s facilities in Rhode Island, Peru, Ecuador, and Mexico are considered direct patient services, where contracts exist between the Company and individual patients [90]. - The approximate CMS reimbursement rates for PBRT treatments in 2025 are $578 for simple treatments and $1,276 for intermediate and complex treatments [92]. - The Company’s revenue recognition policies are based on ASC 842 and ASC 606, with revenues recognized when services are rendered and collectability is reasonably assured [96]. Related Party Transactions - The Company recorded total related party transactions of $1,558,000 for the three months ended March 31, 2025, compared to $2,586,000 for the same period in 2024 [142]. Equipment and Salvage Value - The Company has not assigned any salvage value to its PBRT or LINAC equipment as of March 31, 2025 [101].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTER ENDED March 31, 2025 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-08187 NEW CONCEPT ENERGY, INC. (State or Other Jurisdiction of Incorporation or Organization) Nevada 75-2399477 (I.R.S. Employer Identification No.) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _____________. OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION ...

Revenue Performance - For the three months ended March 31, 2025, the company's revenue was $587,078, a decline of 9.6% compared to $649,420 for the same period in 2024, attributed to fewer subscribers and lower revenue per subscriber [107]. - Average subscribers for the three months ended March 31, 2025, were 2,707, down from 2,996 in the prior year, with average monthly revenue per subscriber decreasing from $72.19 to $69.22 [107]. - The company expects significant future revenue growth from its new educational offerings, which are currently contributing to other revenue streams [107]. Financial Losses - The company incurred an operating loss of $887,666 and a net loss of $829,133 for the three months ended March 31, 2025, compared to a loss from operations of $863,711 in the prior year [98][110]. - EBITDA for the three months ended March 31, 2025, was $(675,044), compared to $(740,927) for the same period in 2024, reflecting adjustments for interest expense and financing costs [115]. Cost and Expenses - Gross margins for the three months ended March 31, 2025, were 41.6%, down from 44.9% in the same period of 2024, with cost of revenues at $343,003 compared to $357,958 [108]. - Operating expenses decreased slightly to $1,131,741 for the three months ended March 31, 2025, from $1,155,428 in the prior year, with a significant increase in selling, general, and administrative expenses due to higher professional fees related to the pending merger [109]. Cash and Financing - The company had cash and marketable securities totaling $215,346 as of March 31, 2025, compared to $17,036 at December 31, 2024 [103]. - The company entered into a merger agreement with REalloys, expected to provide $5,000,000 in financing upon completion, with pre-merger stockholders retaining approximately 7.3% of the post-merger common stock [98]. - The company filed a shelf registration statement for the sale of up to $50,000,000 in securities, with no assurance of being able to raise capital on acceptable terms [100].

Revenue and Income - Total revenues for Q1 2025 increased to $2,339 million, up 40% from $1,670 million in Q1 2024[16] - Net investment income surged to $1,275 million in Q1 2025, compared to $440 million in Q1 2024, reflecting a significant increase of 190%[16] - The company reported a net loss of $203 million for Q1 2025, contrasting with a net income of $114 million in Q1 2024[19] - Comprehensive income attributable to American National Group Inc. was $124 million for Q1 2025, down from $163 million in Q1 2024[19] - For the three months ended March 31, 2025, the net income was a loss of $203 million, compared to a net income of $114 million for the same period in 2024[25] - The company reported a significant increase in insurance-related liabilities, which rose to $652 million from $238 million year-over-year[25] - The company experienced losses on investments and derivatives amounting to $308 million, compared to gains of $47 million in the previous year[25] Assets and Liabilities - Total assets rose to $123,434 million as of March 31, 2025, compared to $121,221 million at the end of 2024, marking an increase of 1.8%[13] - The company’s total liabilities increased to $113,389 million as of March 31, 2025, compared to $111,193 million at the end of 2024, an increase of 2%[13] - The company’s equity totaled $10,045 million as of March 31, 2025, slightly up from $10,028 million at the end of 2024[13] - The total financial liabilities increased to $9,538 million as of March 31, 2025, compared to $9,324 million as of December 31, 2024, reflecting an increase of approximately 2.3%[90] - The total liabilities of the Company as of March 31, 2025, were $110.234 billion, an increase from $107.791 billion as of December 31, 2024[199] Cash Flow and Investments - Cash flows provided by operating activities increased to $671 million, up from $262 million year-over-year[25] - Cash flows used in investing activities significantly increased to $(5,748) million, compared to $(1,538) million in the prior year[27] - The cash and cash equivalents at the end of the period were $7,520 million, a decrease from $11,330 million at the beginning of the period[27] - The fair value of cash and cash equivalents decreased to $7,520 million as of March 31, 2025, from $11,330 million as of December 31, 2024, a decline of approximately 33.5%[90] - The company held excess collateral of $16 million as of March 31, 2025, down from $76 million as of December 31, 2024[86] Premiums and Claims - Net premiums decreased to $889 million in Q1 2025, down 22% from $1,144 million in Q1 2024[16] - The net amount of policyholder benefits and claims incurred was $888 million for the three months ended March 31, 2025, down from $1,086 million in 2024, a decrease of about 18.2%[128] - The liability for unpaid claims increased to $1,908 million as of March 31, 2025, compared to $1,854 million at the end of 2024, reflecting a growth of 2.9%[157] - Total incurred claims for the current accident year were $291 million for the three months ended March 31, 2025, down from $343 million for the same period in 2024[157] Acquisitions and Intangible Assets - The acquisition of AEL was completed for approximately $2.5 billion in cash and 28,803,599 shares of BAM, with goodwill recognized at $662 million as of March 31, 2025[136][137] - The total intangible assets as of March 31, 2025, amounted to $1,654 million, compared to $1,601 million at the end of December 31, 2024, reflecting an increase of about 3.3%[133] - The total value of business acquired (VOBA) decreased to $8,718 million as of March 31, 2025, down from $8,913 million at the beginning of the period, a reduction of approximately 2.2%[130] Equity and Stock Transactions - The company redeemed 16,000 shares of Series A preferred stock for a total payment of $408 million on February 24, 2025, recognizing a loss of $11 million[173] - The company issued 12,000 shares of Series D preferred stock with a liquidation preference of $25,000 per share for net proceeds of $292 million on January 10, 2025[175] Segment Performance - For the three months ended March 31, 2025, the Company reported segment revenues of $2,400 million, an increase from $1,708 million in the same period of 2024, representing a growth of approximately 40.5%[194] - The Distributable Operating Earnings (DOE) for the Annuities segment was $407 million for Q1 2025, compared to $105 million in Q1 2024, indicating a significant increase of approximately 287.6%[194] - The Life Insurance segment generated $152 million in revenues for Q1 2025, a decrease from $311 million in Q1 2024, reflecting a decline of approximately 51.1%[194] Regulatory and Accounting Changes - The amendments in ASU 2023-09 will require public business entities to disclose specific categories in the rate reconciliation starting from annual reporting periods after December 15, 2024[44] - The company is currently evaluating the impact of ASU 2024-03, which will require additional expense category disclosures starting from annual reporting periods after December 15, 2026[45]

Exhibit 99.1 NextPlat Reports First Quarter 2025 Results Company Reports $14.5M in Q1 Revenue; Operating Expenses Decline 26% as Expected, with Continued Focus on Cost Reduction, Ef iciency Improvements, and Strategic Planning Amid Rising Drug Prices and Potential Tarif Impacts COCONUT GROVE, FL – May 15, 2025 – NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced the financial results for the quarter-ended March 31, 2025, reflecting the performanc ...

Financial Performance - Total income for the three months ended March 31, 2025, was $8,238, a significant drop from $5,108,715 in the same period of 2024, indicating a decrease of over 99%[10] - Distributable income for the three months ended March 31, 2025, was $0, compared to $4,092,544 in the same period of 2024, reflecting a complete loss of distributable income year-over-year[10] - Royalty income for the three months ended March 31, 2025, was $0, compared to $5,091,060 in the same period of 2024, marking a decline of 100%[10] - Distributions declared per unit for the three months ended March 31, 2025, were $0, compared to $0.087806 in the same period of 2024[12] - Production Costs exceeded Gross Proceeds by $491,938 for the three months ended March 31, 2025, leading to no Royalty Income distribution[70] - Total Gross Proceeds increased by approximately $5.5 million, or 30.1%, for the three months ended March 31, 2025, compared to the same period in 2024, driven by increased production volumes from two new horizontal wells drilled in 2024[71] Cash and Reserves - As of March 31, 2025, cash and short-term investments decreased to $258,521 from $760,920 on December 31, 2024, representing a decline of approximately 66%[8] - The cash reserve balance was $258,521 as of March 31, 2025, down from $760,920 at the end of 2024, indicating a reduction of approximately 66%[24] - Total cash reserves were $258,521 as of March 31, 2025, down from $1,800,000 as of April 30, 2024, due to the lack of Royalty Income[81] - The Trust expects to continue drawing on cash reserves for all liabilities not covered by interest income until Royalty Income resumes[83] Trust Viability and Concerns - The trust's ability to continue as a going concern is in doubt due to anticipated deficits in income to cover liabilities, prompting evaluations of commercial lending options[25] - The anticipated deficit in income raises substantial doubt about the Trust's ability to continue as a going concern within one year after the issuance date of the financial statements[84] - The Trustee is negotiating a commercial line of credit to cover the Trust's liabilities once cash reserves are depleted[84] Production and Expenditures - Hilcorp's estimated capital expenditures for 2025 are approximately $9.0 million, with $4.0 million allocated to seven new vertical drill projects[39] - Hilcorp's capital expenditures rose significantly from $990,794 for the three months ended March 31, 2024, to $14,047,360 for the same period in 2025, an increase of approximately $13,056,566[72] - The cumulative balance of Excess Production Costs as of March 31, 2025, was $21,739,946 gross ($16,304,960 net to the Trust), which must be recovered from future Net Proceeds before Royalty Income can be paid[77] - Natural gas production from the Subject Interests increased from 5,595,016 Mcf for the three months ended March 31, 2024, to 7,620,893 Mcf for the same period in 2025[70] - Oil production volumes increased by 2,528 Bbls (41.5%) for the Subject Interests and by 41 Bbls (11.4%) for Royalty for the three months ended March 31, 2025[91] Tax and Compliance - The Trust's tax years 2021 and thereafter remain subject to examination, with material tax positions likely to be sustained[32] - Hilcorp's production and sale of natural gas from coal seam wells does not qualify for tax credit under Section 45K of the Code[30] - The Trust's auditing process includes detailed analyses of Hilcorp's pricing and rates charged, ensuring compliance with operative Trust agreements[34] - The trust operates under the regulations set forth by the Securities Exchange Act, ensuring transparency and accountability[118] - The trust's compliance with regulatory requirements highlights its commitment to investor protection[118] Governance and Structure - The San Juan Basin Royalty Trust has no directors or executive officers, indicating a streamlined governance structure[118] - Nancy Willis serves as the Director of Royalty Trust Services, responsible for overseeing trust operations[118] - The document does not provide insights into market expansion or new product developments[118] - The absence of executive officers may affect decision-making processes and strategic initiatives[118] - There are no specific financial performance metrics or forecasts provided in the document[118] - The trust's structure as a royalty trust suggests a focus on income generation from oil and gas royalties[118] - The trust's operational framework may influence investment strategies in the energy sector[118]